Glucotrack, Inc. current report, 09 November 2020

Business Context and Reporting Period

This Form 8-K was filed by Integrity Applications, Inc. on November 16, 2020, reporting events occurring on November 9, 2020. The filing discloses the appointment of Shalom Shushan as Chief Technology Officer (CTO) and the terms of his employment agreement with Integrity Applications, Ltd., a wholly owned subsidiary.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It is a current report focused on executive compensation and personnel changes rather than financial performance.

Material Changes

The primary material change is the addition of Shalom Shushan to the executive leadership team. He brings over 20 years of experience in sensor technologies, machine learning, and medical device development, including a recent role as VP of R&D at Crow Technologies, Ltd.

Compensation and Employment Terms

  • Base Salary: NIS 41,250 per month.
  • Overtime Compensation: NIS 13,750 per month (global payment).
  • Restricted Stock Units (RSUs):
    • Initial award: NIS 90,000 worth of RSUs.
    • Annual awards: NIS 60,000 worth of RSUs on each anniversary.
    • Valuation floor: Stock price at grant date, not lower than US$ 0.40 per share.
    • Vesting: 1/12 of the award vests three months after the start date, with subsequent 1/12 portions vesting every three months thereafter.
  • Annual Incentive: Target up to NIS 60,000 based on performance metrics, subject to Board discretion.
  • Vacation: 23 annual days.

Risks and Contingencies

The filing notes that the Company retains full discretion to amend or cancel the Annual Incentive Bonus Plan at any time. No other specific risks or contingencies are detailed in this report.

Investor Verification Checklist

  • Verify the current share price to calculate the exact number of RSUs granted based on the NIS 90,000 and NIS 60,000 values.
  • Review the Company's Share Incentive Plan to understand the specific terms governing the RSU grants.
  • Monitor future filings for the impact of the new CTO on the company's product roadmap and R&D expenditures.
  • Confirm the exchange rate between NIS and USD for accurate compensation valuation.